First identified in a family of Japanese origin (Funayama et al., 2002) and subsequently independently confirmed in several other families from different countries, leucine-rich repeat kinase 2 (LRRK2) mutations are the most common group of mutations in PD cases (Cookson, 2015). Here, LRRK2 is linked to Parkinson disease.